UK Markets close in 3 hrs 51 mins

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
7.24-4.76 (-39.67%)
As of 07:12PM GMT. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    Why Shares of Pacific Biosciences of California Are Under Pressure Today

    The stock of Pacific Biosciences of California (NASDAQ: PACB), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures missed expectations, driving the stock 11.8% lower as of 12:54 p.m. ET on Tuesday. Preliminary sales figures from the fourth quarter weren't bad, but they were slightly less than the market was expecting.

  • Simply Wall St.

    Investors one-year losses grow to 75% as the stock sheds US$616m this past week

    As every investor would know, you don't hit a homerun every time you swing. But it should be a priority to avoid...

  • Motley Fool

    Should You Invest in Invitae Right Now?

    Genetic testing company Invitae (NYSE: NVTA) has seen its shares tumble from their highs despite aggressively ramping up its test volumes this year. Investors could buy the dip on Invitae, but they shouldn't ignore a major hang-up on its business model. Invitae generates revenue by administering genetic tests while steadily also building a genome information database over time.